Gestational Trophoblastic Neoplasia Clinical Trials

16 clinical trials for Gestational Trophoblastic Neoplasia across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia — RECRUITING · PHASE3
• Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule — RECRUITING · NA
• Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia — RECRUITING · PHASE2
• The Psychological Impact of GTN on Women Who Have Completed Chemotherapy Treatment — RECRUITING
• Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6 — RECRUITING · NA
• Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7 — RECRUITING · PHASE2
• Clinical Specialty Queue For Gestational Trophoblastic Neoplasia — RECRUITING
• Uterine Artery Doppler Flow Velocimetry Parameters for Predicting the Occurrence of Persistent Gestational Trophoblastic Neoplasia After Evacuation of Complete Hydatiform Mole — NOT_YET_RECRUITING
• Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia — ACTIVE_NOT_RECRUITING · NA
• A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia — OTHER · PHASE2
• Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia — WITHDRAWN · PHASE2
• Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy — OTHER · PHASE2
• Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia — OTHER · PHASE3
• Phase 2 Trial for Chemo-Resistant Gestational Trophoblastic Neoplasias With Pembrolizumab (CR-GTP) — OTHER · PHASE2
• Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia — OTHER · PHASE3
• Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) — TERMINATED · PHASE2

Refine this search